Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Boston Scientific Corporation BSX
$52.98
-$0.41 (-0.78%)
На 18:00, 12 мая 2023
+9.34%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
76140590305.00000000
-
week52high
53.67
-
week52low
34.98
-
Revenue
12682000000
-
P/E TTM
82
-
Beta
0.79653900
-
EPS
0.60000000
-
Last Dividend
0.00000000
-
Next Earnings Date
25 июл 2023 г. в 12:30
Описание компании
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Raymond James | Strong Buy | Strong Buy | 28 июл 2022 г. |
| Morgan Stanley | Overweight | Overweight | 28 июл 2022 г. |
| BTIG | Buy | Buy | 28 июл 2022 г. |
| Truist Securities | Buy | Buy | 20 июл 2022 г. |
| Morgan Stanley | Overweight | Overweight | 15 июл 2022 г. |
| Piper Sandler | Overweight | Overweight | 09 сент 2022 г. |
| Jefferies | Buy | 12 окт 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
| Barclays | Overweight | 18 окт 2022 г. | |
| Raymond James | Strong Buy | Strong Buy | 08 дек 2022 г. |
| Morgan Stanley | Overweight | Overweight | 06 янв 2023 г. |
| Mizuho | Neutral | 22 дек 2022 г. | |
| Truist Securities | Buy | Buy | 20 дек 2022 г. |
| Raymond James | Strong Buy | Strong Buy | 02 февр 2023 г. |
| Needham | Buy | Buy | 02 февр 2023 г. |
| JP Morgan | Overweight | Overweight | 02 февр 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Mirviss Jeffrey B. | D | 88479 | 6751 | 04 янв 2023 г. |
| Brennan Daniel J. | D | 0 | 13134 | 01 янв 2023 г. |
| Brennan Daniel J. | D | 273382 | 4042 | 01 янв 2023 г. |
| Brennan Daniel J. | A | 277424 | 13134 | 01 янв 2023 г. |
| Butcher Arthur C | D | 0 | 8405 | 01 янв 2023 г. |
| Butcher Arthur C | D | 35358 | 3904 | 01 янв 2023 г. |
| Butcher Arthur C | A | 39262 | 8405 | 01 янв 2023 г. |
| Carruthers Wendy | D | 0 | 6567 | 01 янв 2023 г. |
| Carruthers Wendy | D | 90880 | 3100 | 01 янв 2023 г. |
| Carruthers Wendy | A | 93980 | 6567 | 01 янв 2023 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 40165000 | -369195 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 29353600 | -107729 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 15068400 | -71463 | 31 авг 2020 г. |
| US Bank Vanguard Institutional 500 Index Trust | 12275200 | -56063 | 31 авг 2020 г. |
| Fidelity 500 Index Fund | 12726000 | -13772 | 31 июл 2020 г. |
| Vanguard Health Care Fund | 36684200 | 4427880 | 30 июн 2020 г. |
| Vanguard PRIMECAP Fund | 29273200 | -360000 | 30 июн 2020 г. |
| American Funds New Perspective Fund | 23606700 | -184962 | 30 июн 2020 г. |
| American Funds Growth Fund of America | 20292800 | -442608 | 30 июн 2020 г. |
| American Funds Fundamental Investors Fund, Inc. | 13037700 | 0 | 30 июн 2020 г. |
Новостная лента
Shockwave Tumbles As Boston Scientific Takeover Talk Reportedly Breaks Down
Investors Business Daily
08 мая 2023 г. в 12:18
The rumored matchup between Boston Scientific and Shockwave Medical reportedly broke down on Monday, leading SWAV stock into a dive. The post Shockwave Tumbles As Boston Scientific Takeover Talk Reportedly Breaks Down appeared first on Investor's Business Daily.
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research
28 апр 2023 г. в 11:24
Here is how Boston Scientific (BSX) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Can Boston Scientific Set Another Net High?
MarketBeat
27 апр 2023 г. в 07:18
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Boston Scientific (BSX) Q1 Earnings Beat, 2023 View Raised
Zacks Investment Research
26 апр 2023 г. в 12:11
Reported and organic revenues at each of Boston Scientific's (BSX) core business segments and geographies increase in the reported quarter.
Boston Scientific (BSX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks Investment Research
26 апр 2023 г. в 11:28
The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.